PSA's Psychedelic State(s) of The Union: May 12th, 2026

By Jack Gorsline

From our friends at Lucid News

The modern psychedelic renaissance is exhibiting rapid expansion, shifting legislative boundaries, and an influx of both medical professionals and countercultural opportunists. All of these elements collided last month at PsyCon Denver 2026.

Held at the expansive Denver Convention Center, the biannual conference operates with a significantly smaller budget and a more modest physical footprint than massive industry megaconferences such as the Multidisciplinary Association for Psychedelic Studies’ (MAPS) Psychedelic Science which takes place in the same location. Rather than filling sprawling arenas with thousands of medical researchers and venture capitalists, this year’s PsyCon expo featured an intimate exhibition hall and two small conference rooms dedicated to speakers and discussion panels during the day.

Despite its smaller scale, the gathering provided a vivid snapshot of an industry caught in an awkward transitional phase. As the psychedelic sector attempts to bridge the gap between ancient ceremonial practices and modern clinical frameworks, PsyCon Denver showcased the growing pains of a market trying to establish its identity.

Gray Market Products Dominate 

Perhaps nowhere was this tension more apparent than on the exhibition floor, where the line between legal advocacy and illicit commerce was routinely blurred.

Under current Colorado law, retail sales of classic psychedelics -  including psilocybin, DMT, LSD, and other entheogenic compounds  remain strictly illegal. While recent ballot measures and legislative reforms have decriminalized the personal possession, cultivation, and communal sharing of certain natural medicines, the establishment of a traditional retail dispensary model for these substances is prohibited.

Despite this clear legal parameter, the gray market vendors present on the exhibit floor at PsyCon Denver were not shy in their sales-oriented approach to conference attendees. Operating in a brazen regulatory twilight zone, numerous exhibitors openly displayed and marketed products that tested the boundaries of local and federal law.

Among the more prominent vendors in question was a California-based entheogenic church, which offered psychoactive sacraments to those who wished to pay for them.  Just a few aisles over, a mushroom chocolate bar company set up a vibrant booth featuring an array of beautifully packaged consumer products on display. The infused chocolates were situated front and center, actively marketed, and very much for sale to the general public wandering the convention center floor.

The presence of these gray market vendors created a striking juxtaposition against the more traditional, officially sanctioned exhibitors sharing the same carpeted hall. Alongside the companies hawking illicit or quasi-legal chocolate bars were legacy advocacy groups such as Decriminalize Nature and MAPS - organizations that have spent decades lobbying for careful, rigorous legislative reform.

Adding to the surreal atmosphere of the exhibition hall were official representatives from the Colorado Department of Public Health and Environment. These state employees shared the same breathing room as underground vendors, highlighting the complex and often contradictory reality of Colorado’s current drug policy enforcement.

Rounding out the exhibition floor was a vast array of companies hawking alternative wellness products designed to capitalize on the psychedelic boom without crossing legal lines. These businesses offered everything from legal Amanita muscaria mushroom tinctures to high-end infrared saunas and vibroacoustic sound therapy beds, demonstrating the lucrative ecosystem of peripheral therapies that has sprouted up around the psychedelic community.

AI and Psychedelics Discourse Lacking in Substance 

Away from the bustling commerce of the exhibition hall, the conference’s educational programming drew attendees into two small, densely packed rooms. Among the most highly anticipated topics of the weekend was the intersection of artificial intelligence and psychedelic therapies -  two of the decade’s most heavily funded and fiercely debated technological frontiers.

However, the discourse surrounding this technological convergence largely lacked substantive, actionable data. This was most evident during a keynote presentation delivered by Joey Bothwell titled, “Psychedelics, AI and the Currency of Consciousness.”

Early in the presentation, Bothwell captivated the audience with a bold, pop-culture-infused declaration, suggesting that the marriage of artificial intelligence and psychedelic medicine could become "the Taylor Swift and Travis Kelce of consciousness." The metaphor implied a massive, inevitable, and culturally dominant union. 

Yet, despite the growing interest from both Silicon Valley investors and neuroscientists regarding machine learning's potential to map brain states or synthesize novel compounds, Bothwell's presentation did not include a single tangible example of AI’s possible use applications in actual psychedelic care or clinical therapy.

Instead of focusing on data sets, algorithmic drug discovery, or patient safety guardrails, the presentation veered into sweeping philosophical speculation about the future of humanity in an automated world.

“We don't stand a chance. AI has us beat across the board. It will have the external world on lock. We designed it that way,” Bothwell told the audience. “But I'm not trying to think of this as a bad thing. In fact, I'm trying to think of it as an excellent thing, because if I don't have to worry about dealing with my printer or my coffee in the morning or the magic number that the IRS makes me guess every April fifteenth, I'm going to be able to be freed up to do the work that I actually wanna do, the work that I'm actually interested in, that I know that you all are interested in, and in my opinion, that we as a collective species are being forced to engage with right now.”

The speech underscored a frequent criticism leveled at the modern psychedelic community by scientific observers: a tendency to favor grandiose, utopian rhetoric over rigorous, practical implementation. Bothwell acknowledged the inherent uncertainty of a future dominated by artificial intelligence, framing psychedelics as a tool for grounding humans as they navigate an impending loss of traditional societal purpose.

“It’s a huge question that's on all of our minds, right? I think just across the board, we're all trying to figure out what our place is gonna be in that," Bothwell stated. "And my opinion, right, because nobody can foresee the future. We also don't know the full scope of what's going to happen."

Bothwell concluded the session by proposing that psychedelic experiences will ultimately define human value in a post-labor economy.

"I deeply believe, and this might be an unpopular opinion, is that one day, that is going to be the currency of status in the humanity of our human species," Bothwell said. "If we take away money, and we take away power, what do we really have? If the robots are doing everything for us, and we all have, you know, a universal income, there is going to be status created within our human species. And I deeply believe it's going to be based on how embodied you are, how aligned you are with your own consciousness."

While the philosophical approach resonated with the countercultural roots of the audience, it left those seeking concrete advancements in the psychedelic industry looking toward the next conference on the horizon.

As the doors closed on PsyCon Denver 2026, the underlying narrative of the weekend was undeniable: the modern psychedelic movement is standing at a complex regulatory and cultural crossroads. Between the unchecked commercialization of gray market vendors operating in broad daylight and the lofty, ungrounded speculation surrounding emerging technologies, the industry is actively struggling to define its legitimate future. 

For the psychedelic sector to successfully transition from its underground, countercultural roots into the mainstream clinical and wellness landscapes some clearly covet, it may need to reconcile internal contradictions. As regulatory and cultural consensus is debated, gatherings like PsyCon continue to serve as a fascinating, albeit chaotic, microcosm of an industry bracing for whatever comes next.

A recent blog post written by psychedel*c mega donor David Bronner - who donated over $1 Million dollars to the failed Yes on 4 Psychedelics ballot campaign in Massachusetts back in 2024 - has drawn the ire of former Yes on 4 Campaign staffers.

In the post, Bronner erroneously claimed that the initiative failed in part due to an unfriendly ballot question summary that confused voters and a miscalculation about the importance of a paid media campaign to reach voters.

However, as PSA founder Jack Gorsline breaks down in this segment, the math behind Bronner’s evolving spin-job to defend the massive failure of the Q4 campaign simply doesn’t add up.

Previous reporting by Lucid News and the Boston Institute for Nonprofit Journalism (BINJ) last year revealed that the Q4 campaign canceled nearly $1 million in previously reserved TV ads just weeks before the election, despite a campaign budget of over $7.5 million dollars.

Source: ‪Psychedelic State(s) of America's Monday News Roundup — powered by ‪Psychedelics Today — May 11th, 2026

Learn more about PSA’s Media Partnership Program Here

Until next time,

The Psychedelic State(s) of America Team